Todays Report: Today, Amica Retiree Medical Trust reduces its investment in Anthem Inc. (ANTM)

Today, Amica Retiree Medical Trust reduces its investment in Anthem Inc. (ANTM)

Amica Retiree Medical Trust reduced its stake in Anthem Inc. (NYSE:ANTM) by 14.4% during the third quarter, according to its most recent filing with the SEC. The firm owned 1,552 shares of the company’s stock after selling 261 shares during the period. Amica Retiree Medical Trust’s holdings in Anthem were worth $194,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. NEXT Financial Group Inc raised its position in Anthem by 51.2% in the third quarter. NEXT Financial Group Inc now owns 803 shares of the company’s stock valued at $101,000 after buying an additional 272 shares in the last quarter. Financial Architects Inc raised its position in Anthem by 2.7% in the second quarter. Financial Architects Inc now owns 839 shares of the company’s stock valued at $111,000 after buying an additional 22 shares in the last quarter. Integrated Investment Consultants LLC raised its position in Anthem by 21.4% in the second quarter. Integrated Investment Consultants LLC now owns 850 shares of the company’s stock valued at $112,000 after buying an additional 150 shares in the last quarter. Global X Management Co. LLC raised its position in Anthem by 50.6% in the second quarter. Global X Management Co. LLC now owns 920 shares of the company’s stock valued at $121,000 after buying an additional 309 shares in the last quarter. Finally, Invictus RG raised its position in Anthem by 338.5% in the second quarter. Invictus RG now owns 1,013 shares of the company’s stock valued at $133,000 after buying an additional 782 shares in the last quarter. 89.13% of the stock is currently owned by hedge funds and other institutional investors.

Anthem Inc. (NYSE:ANTM) traded up 0.78% during trading on Friday, hitting $144.74. The company had a trading volume of 1,231,477 shares. The firm’s 50 day moving average is $126.84 and its 200-day moving average is $129.36. The stock has a market capitalization of $38.13 billion, a price-to-earnings ratio of 16.99 and a beta of 0.57. Anthem Inc. has a 52-week low of $114.85 and a 52-week high of $148.00.

Anthem (NYSE:ANTM) last posted its quarterly earnings data on Wednesday, November 2nd. The company reported $2.45 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.47 by $0.02. The company had revenue of $21.13 billion for the quarter, compared to analysts’ expectations of $20.77 billion. Anthem had a return on equity of 11.64% and a net margin of 2.74%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the business posted $2.73 EPS. On average, equities analysts forecast that Anthem Inc. will post $10.81 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 21st. Investors of record on Monday, December 5th will be given a dividend of $0.65 per share. The ex-dividend date of this dividend is Thursday, December 1st. This represents a $2.60 dividend on an annualized basis and a dividend yield of 1.80%. Anthem’s payout ratio is currently 30.52%.

Several research analysts have issued reports on the company. Wells Fargo & Co. upgraded Anthem from a “market perform” rating to an “outperform” rating in a research report on Tuesday, November 15th. Zacks Investment Research upgraded Anthem from a “sell” rating to a “hold” rating in a research report on Tuesday, September 13th. Jefferies Group lowered Anthem from a “buy” rating to a “hold” rating and lowered their price target for the company from $156.00 to $138.00 in a report on Tuesday, September 13th. Evercore ISI assumed coverage on Anthem in a report on Thursday, September 22nd. They issued a “hold” rating and a $133.00 price target for the company. Finally, JPMorgan Chase & Co. lowered Anthem from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $154.00 to $132.00 in a report on Monday, October 17th. Eight research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Anthem currently has a consensus rating of “Buy” and a consensus target price of $158.05.

In other Anthem news, insider Joseph Swedish sold 24,513 shares of the firm’s stock in a transaction that occurred on Friday, November 11th. The shares were sold at an average price of $131.48, for a total value of $3,222,969.24. Following the completion of the transaction, the insider now owns 87,381 shares of the company’s stock, valued at approximately $11,488,853.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Ronald W. Penczek sold 820 shares of the firm’s stock in a transaction that occurred on Tuesday, November 22nd. The shares were sold at an average price of $138.29, for a total transaction of $113,397.80. Following the completion of the transaction, the senior vice president now directly owns 1,320 shares of the company’s stock, valued at approximately $182,542.80. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company’s stock.

Anthem Company Profile

Anthem, Inc is a health benefit company. The Company offers a range of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. The Company has three segments: Commercial and Specialty Business, Government Business and Other. The Company’s Commercial and Specialty Business, and Government Business segments offer managed care products, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), traditional indemnity benefits and point-of-service (POS) plans, as well as various hybrid benefit plans, including consumer-driven health plans (CDHPs), hospital only and limited benefit products.

Related posts

Leave a Comment